Fiche centre
Royal Free London NHS Foundation Trust
London — United Kingdom
Essais liés3clinical trials
VilleLondonlocalisation
PaysUnited Kingdomlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07714538
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Cladribine (MAVENCLAD®) | SEP | Phase 2/3 | NCT04695080 | ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis | ACTIVE_NOT_RECRUITING |
| BRAVE — Breath Research Narrow Validation for Gastrointestinal Cancer Detection | Cancer | À vérifier | NCT07714538 | BRAVE — Breath Research Narrow Validation for Gastrointestinal Cancer Detection | RECRUITING |
| M5049 dose | Myopathies | Phase 2 | NCT05650567 | Study of M5049 in DM and PM Participants (NEPTUNIA) | TERMINATED |